Crisaborole Patent Expiration
Crisaborole is Used for managing mild to moderate atopic dermatitis. It was first introduced by Anacor Pharmaceuticals Inc
Crisaborole Patents
Given below is the list of patents protecting Crisaborole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Eucrisa | US8039451 | Boron-containing small molecules | Jun 29, 2029 | Anacor Pharms Inc |
| Eucrisa |
US8039451 (Pediatric) | Boron-containing small molecules | Dec 29, 2029 | Anacor Pharms Inc |
| Eucrisa | US8168614 | Boron-containing small molecules as anti-inflammatory agents | Jan 20, 2030 | Anacor Pharms Inc |
| Eucrisa |
US8168614 (Pediatric) | Boron-containing small molecules as anti-inflammatory agents | Jul 20, 2030 | Anacor Pharms Inc |
| Eucrisa | US8501712 | Boron-containing small molecules as anti-inflammatory agents | Feb 16, 2027 | Anacor Pharms Inc |
| Eucrisa |
US8501712 (Pediatric) | Boron-containing small molecules as anti-inflammatory agents | Aug 16, 2027 | Anacor Pharms Inc |
| Eucrisa | US9682092 | Boron-containing small molecules as anti-inflammatory agents | Feb 16, 2027 | Anacor Pharms Inc |
| Eucrisa |
US9682092 (Pediatric) | Boron-containing small molecules as anti-inflammatory agents | Aug 16, 2027 | Anacor Pharms Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳